CASSAVA SCIENCES INC

Cassava Sciences Inc.

Biotechnology • Healthcare • Austin, TX, United States • SAVA (NCM)

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

512 501 2444 6801 N. Capital of Texas Highway, Austin, TX 78731, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cassava Sciences (SAVA): Evaluating Valuation After CEO’s Major Share Purchase and Alzheimer’s Program Withdrawal - Yahoo Finance
Yahoo Finance • Sep 27
Cassava Sciences stock falls after FDA places clinical trial on hold - Investing.com
Investing.com • Dec 19
Cassava Sciences drops on delay for epilepsy study - Seeking Alpha
Seeking Alpha • Dec 19
LUCID CAPITAL MARKETS Initiates Coverage of Cassava Sciences (SAVA) with Buy Recommendation - Nasdaq
Nasdaq • Oct 6
Cassava Sciences Stock On Track For Worst Day In About 9 Months — What’s Driving Today’s Selloff? - Stocktwits
Stocktwits • Dec 19

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has CASSAVA SCIENCES INC had layoffs?
No layoff events have been recorded for CASSAVA SCIENCES INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does CASSAVA SCIENCES INC have?
CASSAVA SCIENCES INC has approximately 30 employees.
What industry is CASSAVA SCIENCES INC in?
CASSAVA SCIENCES INC operates in the Biotechnology industry, within the Healthcare sector.
Is CASSAVA SCIENCES INC a publicly traded company?
Yes, CASSAVA SCIENCES INC is publicly traded under the ticker symbol SAVA on the NCM. The company has a market capitalization of approximately $0.11 billion.
Where is CASSAVA SCIENCES INC headquartered?
CASSAVA SCIENCES INC is headquartered in Austin, TX, United States at 6801 N. Capital of Texas Highway, Austin, TX 78731, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.